INTERMEDIATE MONOCYTE AND PLATELET ACTIVATION WITHIN THE EXTRACORPOREAL HEMODIALYSIS CIRCUIT AS NEW MARKERS FOR HEMODIALYSIS-ASSOCIATED THROMBOINFLAMMATION

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/2abefadf54dc301ce2a1aa2279d16e6e.pdf
INTERMEDIATE MONOCYTE AND PLATELET ACTIVATION WITHIN THE EXTRACORPOREAL HEMODIALYSIS CIRCUIT AS NEW MARKERS FOR HEMODIALYSIS-ASSOCIATED THROMBOINFLAMMATION

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Florine
Janssens
Florine Janssens florine.janssens@uzbrussel.be Universitair Ziekenhuis Brussel (UZ Brussel) Department of Nephrology & Arterial Hypertension Brussels Belgium * Vrije Universiteit Brussel (VUB) Kidney diseases, dialysis & transplantation Research Unit (NIER), Vitality Research Group Brussels Belgium
Wim Renmans wim.renmans@telenet.be Universitair Ziekenhuis Brussel (UZ Brussel) Department of Clinical Biology, Laboratory of Hematology Brussels Belgium -
Eleni Linskens eleni.linskens@uzbrussel.be Universitair Ziekenhuis Brussel (UZ Brussel) Department of Clinical Biology, Laboratory of Hematology Brussels Belgium -
Freya Van Hulle Freya.VanHulle@uzbrussel.be Universitair Ziekenhuis Brussel (UZ Brussel) Department of Nephrology & Arterial Hypertension Brussels Belgium - Vrije Universiteit Brussel (VUB) Kidney diseases, dialysis & transplantation Research Unit (NIER), Vitality Research Group Brussels Belgium
Priya Laha plaha@vub.be Vrije Universiteit Brussel (VUB) Research Group Electrochemical and Surface Engineering (SURF), Department of Materials and Chemistry Brussels Belgium -
Tom Hauffman tom.hauffman@vub.be Vrije Universiteit Brussel (VUB) Research Group Electrochemical and Surface Engineering (SURF), Department of Materials and Chemistry Brussels Belgium -
Stefaan Verhulst stefaan.verhulst@vub.be Vrije Universiteit Brussel (VUB) Liver Cell Biology Research Group (LIVR) Brussels Belgium -
Karlien François karlien.francois@uzbrussel.be Universitair Ziekenhuis Brussel (UZ Brussel) Department of Nephrology & Arterial Hypertension Brussels Belgium - Vrije Universiteit Brussel (VUB) Kidney diseases, dialysis & transplantation Research Unit (NIER), Vitality Research Group Brussels Belgium
-
-
-
-
-
-
-

During hemodialysis (HD), blood exposure to the extracorporeal circuit (ECC) triggers plasma protein and cell adhesion to the ECC and activates leukocytes, platelets, coagulation and complement pathways. Pro-thromboinflammatory signals spreading to the patient’s circulation contributes to systemic thromboinflammation, a major driver of cardiovascular (CV) disease, the leading cause of mortality in HD patients. Yet, the thromboinflammatory processes within the ECC—key drivers of systemic responses—remain poorly understood. This study aims to describe and quantify thromboinflammatory cell activation within the ECC.

In this exploratory pilot study, 3 clinically stable HD patients underwent 4-hours HD sessions via AV-fistula using heparin. Blood samples were collected pre- and post-HD. After blood retransfusion, the used ECC was rinsed with PBS-EDTA to retrieve circuit-adherent cells, followed by an enzymatic rinse (Accutase®) to detach rinsing-resistant cells. Cell counts (Alinity Hq, Abbott) and flow cytometry (FACSLyric, BD) were performed on both blood samples and rinse fluids. Scanning electron microscopy (SEM) of the used dialyzers was used to validate the efficacy of the rinsing. For each patient, SEM analysis of a used non-rinsed and EDTA-only rinsed dialyzer of a consecutive HD session was performed as control.  

Figure 13 patients (68 ± 13 years, 2 male) were included. The EDTA rinse yielded a median of 14.1 ×106 leukocytes [10.8–17.8 ×106] and 32.8 ×106 platelets [21.4–46.1 × 106]. Subsequent enzymatic rinse yielded a median of 15.3 ×106 leukocytes [5.29–21.1 × 106] and 45.5 ×106 platelets [44–62.4 ×106], despite being performed after blood retransfusion to the patient and EDTA rinsing. Flow cytometric analyses revealed a significant higher proportion of intermediate monocytes and activated platelets in rinse fluids compared to blood samples according to the CD14++CD16+ (intermediate monocyte subset), CD62P+ (platelet degranulation) and PAC1+ (platelet adhesion) expression respectively (Fig.1).  Neutrophils and monocytes were highly activated in both blood samples and rinse fluids, with CD66b and   CD11b expression reaching 100% in all conditions. SEM of a used non-rinsed fiber demonstrated feasibility of visualizing circuit-adherent cells. Remaining cell clusters persisted after EDTA rinsing, but not after enzymatic rinsing (Fig. 2).

Our findings demonstrate that rinsing of the ECC using an EDTA rinsing fluid only is insufficient to retrieve circuit-adherent cells. Our novel two-step protocol – EDTA followed by enzymatic rinsing - enables full retrieval, as visually confirmed by SEM. Further characterization demonstrates the sequestration of intermediate monocytes within the used ECC, a cell population associated to CV events and mortality in HD patients. Platelets, not explored as circuit-adherent cells before, were found to be abundant within the ECC and exhibited increased activation in the rinse fluids compared to blood samples. These findings supports that the ECC acts as a thromboinflammatory origin nidus. Given thromboinflammation’s role as a major driver of CV disease, our protocol offers a novel tool to investigate the cellular mechanisms underlying this phenomenon at ECC-level and enables future investigations into whether modifications to the HD setup can mitigate these responses.

This abstract was also submitted for the ERA25 congress and BVN annual meeting 2025.

Kewords